enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Elexacaftor/tezacaftor/ivacaftor - Wikipedia

    en.wikipedia.org/wiki/Elexacaftor/tezacaftor/...

    In December 2020, after an additional clinical trial was completed, and FDA approval was expanded for 177 other cystic fibrosis mutations. [32] FDA approval for children aged 6–11 was added in January 2021, after a third clinical trial was completed. [33] In 2023, approval was extended to children 2–5. [34]

  3. Newly Published Data Indicates St. Jude Medical Trifecta ...

    www.aol.com/news/2013-03-19-newly-published-data...

    Conducted at 31 medical centers in the U.S., Canada and Europe, the study followed 1,014 eligible patients implanted with the Trifecta valve between 2007 and 2009 as part of a U.S. Food and Drug ...

  4. Zepbound Weight Loss Medication Approved by FDA to Treat ...

    www.aol.com/fda-approves-weight-loss-medication...

    The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.

  5. FDA issues recalls on at least 16 food and drug items in ...

    www.aol.com/fda-issues-recalls-least-16...

    For premium support please call: 800-290-4726 more ways to reach us

  6. Trial master file - Wikipedia

    en.wikipedia.org/wiki/Trial_master_file

    In a clinical trial involving human subjects, a set of content known as a trial master file (TMF) must be produced in accordance with applicable international and local regulations. TMFs are a collection of documents and other artifacts which "individually and collectively permit evaluation of the conduct of a trial and the quality of the data ...

  7. Levomilnacipran - Wikipedia

    en.wikipedia.org/wiki/Levomilnacipran

    The FDA approved levomilnacipran for treating major depressive disorder. This approval was based on the results of five clinical trials.The trials included one 10-week phase II and four 8-week phase III.

  8. Compounding group sues FDA for removing Lilly's weight loss ...

    www.aol.com/news/compounding-group-sues-fda...

    Mounjaro had been on the FDA's list of drugs in short supply since late 2022, while Zepbound was added in April. Compounding facilities create medicines by combining, mixing or altering drug ...

  9. FDA warns against tests from secret Chinese-owned lab in ...

    www.aol.com/news/fda-warns-against-tests-secret...

    For premium support please call: 800-290-4726 more ways to reach us